Table 2.
Spearman correlations of biomarkers with clinical variables
| Serum hsCRP (rs; p) |
Serum CRPM (rs; p) |
Serum C1M (rs; p) |
Serum C3M (rs; p) |
|
|---|---|---|---|---|
| Age | −0.166; 0.428 | −0.108; 0.608 | −0.158; 0.450 | −0.089; 0.671 |
| BMI | 0.625; 0.001 | −0.066; 0.753 | 0.077; 0.715 | 0.011; 0.959 |
| Sum K-L | 0.453; 0.023 | −0.0639; 0.762 | 0.076; 0.720 | −0.072; 0.734 |
| Sum OST | 0.595; 0.002 | 0.320; 0.119 | 0.232; 0.264 | 0.417; 0.038 |
| Sum JSN | 0.182; 0.384 | −0.174; 0.407 | −0.104; 0.620 | −0.114; 0.586 |
| Sum Knee Synovitis | −0.026; 0.901 | 0.474; 0.017 | 0.126; 0.549 | 0.339; 0.098 |
| Multi-Joint Synovitis | −0.284; 0.169 | 0.520; 0.008 | −0.090; 0.670 | 0.344; 0.092 |
| Sum PAS knee pain | 0.048; 0.819 | 0.049; 0.818 | 0.165; 0.430 | 0.010; 0.961 |
| Sum WOMAC knee pain (Q1) | −0.014; 0.947 | 0.132; 0.530 | −0.007; 0.972 | 0.309; 0.134 |
Bolded correlations were significant (p<0.05)
K-L Kellgren-Lawrence knee grade, OST osteophyte knee score, JSN joint space narrowing knee score, PAS pain/aching/stiffness